To my fellow worthy HBRM soldiers and new peeps lacking DD.
I just wanted to lift spirits. I come bearing the fruit of my labor to provide for those that seek it.
I thought this DD should be available on this IHUB page.
The Company has never defaulted on the terms of any note, loan, lease, or other financial arrangement. The Company has successfully negotiated favorable loan terms and payouts.
Whether the issuer is or has at any time been a “shell company”
No
Herborium’s distribution strategy targets following channels:
• E-stores and Affiliates
• B2C Consumer Markets
• Specialty High-end Apothecaries
• National Upscale Pharmacy Chains
• Health and Beauty Market
• Ethnic and Specialty/niche Markets (e.g. Hispanic Market, AfroAmerican Market, Male Market)
• Wholesale Distributors
• Health Care Market
• Selected International Markets (EU and Asia)
Health Care Products Association (CHPA) presented evidence of the strength of the Self-Care Movement in a recent survey. Among those surveyed:
• 73% would rather treat themselves at home then see a doctor.
• 96% say they are generally confident about the health care decisions they make for themselves.
Competitive Position in the industry:
Based on an internal Competitive Corporate Analysis, we believe only 3 or 4 companies are potential competitors of Herborium. We view these companies as aspiring to become “Herbaceutical” companies. The Company does not believe that they maintain a similar level of clinical and regulatory experience that is present in Herborium. Therefore, we do not perceive them as direct competition, they are new and late entrants in the botanical therapeutics market.
Methods of Competition:
It seems that the 3 or 4 potential competitors mentioned above evolved from the herbal and supplement territory and are trying to “upgrade” their products to the status of Botanical Therapeutics® (the trademark owned by Herborium). Because the herbal supplement industry is highly fragmented, Herborium’s bid for leadership in the sector may include strategic mergers and acquisitions, depending on appropriate financial resources.
Patents, trademarks, licenses, franchises, concessions, royalty agreements or labor contracts, including their duration Herborium owns The following Trademarks:
Herborium®, AcnEase®, AcnEase Skin Management System, Botanical Therapeutics®, MaleForce® and MaleForceRR®, It’s Better To Do It Naturally®, Lasting Pleasure®, Lasting Power®, Liver Rejuvenator®, Liver Relief®, Liver Activator Series®, Hep-Aid®, as well as patent application (second level) for Lasting Power and owns 143 domains in the US, Europe and Asia.All the trademarks are presently renewed for the permanent use (No expiration date until in confirmed use). All the domains registration are valid and under the automatic renewal program
Employment History:
Dr. Olszewski, founder of Herborium, has over 20 years experience in business strategy, strategic marketing management and international business. She holds an MA and a Ph.D. degree from Warsaw University, Poland, and an MBA from Fordham University, New York City. Dr. Olszewski has been a consultant and a team leader on strategic management and competitive marketing strategies for leading American corporations as well as foreign companies and institutions. In her capacity as an international consultant she has led multicultural negotiations and managed diverse teams of professionals in the USA, Asia and Europe. She has also been responsible for developing and implementing business and marketing strategies in the US and foreign markets. Dr. Olszewski’s client list includes: AT&T, Johnson & Johnson, Nynex Communications, Unigene Laboratories Inc., Polish Airlines “LOT”, Ministry Of Foreign Trade and Economic Collaboration of PRC, UNDP, Graphica Inc. amongst others. She has also been a Small Business Advisor and the Member of the Global Round Table for the State of New Jersey. Dr. Olszewski has been conducting business in China for nearly 20 years.After the collapse of communism in Central Europe, Dr. Olszewski formed A&T Global Marketing Inc., one of the first consulting firms in the US focusing on the transfer of western management and financial know-how into transitional economies. The company was also involved in advising American corporations on entry strategies into the emerging markets of Europe and Asia. Dr. Olszewski has successfully led the efforts to form Joint Ventures in Poland, China and France. She was President and CEO of G.O International, Inc., a company that she co-founded with Dr. James P. Gilligan. G.O. International, Inc., a consulting firm specializing in business strategies for the pharmaceutical industry and global technology transfer, merged with Herborium, Inc. in June 2002. Prior to starting Herborium, Dr. Olszewski was Director of The Institute for International Business and Director of the MSIB Program at Seton Hall University where she is presently a Professor of Marketing and International Business. Dr. Olszewski is the author of over 100 publications and presentations in the US and abroad. She is a Member of The Women’s Presidents Organization, an Executive Member of the American Marketing Association, Member of the Academy of International Business, American Academy of Management, and the International Platform Association. Dr. Olszewski is a recipient of the Valley Forge Foundation National Economic Excellence Award and a recipient of the International Business Award of the State of New Jersey
Now meet the Dr.’s Investment banker/advisor: Conrad Huss
Conrad was a principal at Berwyn Capital LLC., a boutique Investment Bank focusing on emerging growth companies. Conrad was also the was Managing Director at Hobbs Melville Securities Corp located at 110 Wall Street. Conrad was the CEO for Metrix Instrumental Co. He was also the Managing Director, Corporate Finance at Credit Lyonnais USA, Inc.
To give you an idea of the scope of operations he deals with, read on.
Roper Industries (NYSE=ROP) acquired Metrix in 1995, and the company began to expand its global presence by adding three regional sales and service offices. In 1998, Roper acquired PMC/BETA and combined it with Metrix, further increasing and strengthening the product line. Today, Metrix operates in over 40 countries and is a Limited Partnership of Roper, a $2.8 billion diversified provider of engineered products in analytical instrumentation, industrial controls and fluid handling.
And let’s not forget about the new big man on campus, Mr. Wilen. Folks, they might as well be illuminati! Sheesh, what more do you want? Ughhh,,.. thinking about the sellers is depressing knowing they got serious haircuts. Not this kid! Time to Anny up! I will most likely dump all my other holdings soon enough and go all in here. No joke!
Yes the revenues were not exactly mind blowing in 2011 but the debt burden, or lack thereof, speaks volumes to HBRMs potential. That is why I am 100% confident the merger/buyout will take place and the good Dr. will be ruling the botanical universe in the very near future. As in like next week or possibly the week after.
Speaking on the last PR, I do not blame pumpers. But I was using common sense like everybody else thinking merger/buyout. I believe it was maybe to bring attention to HBRM and at the same time to P&D and pay for merger/buyout expenses. They knew full well the stock would take a hit. I also believe CHRI has also begun the process of the merger/buyout buying the panic. This of course is more profitable for CHRI to do. Let’s face it folks. People were scammed and scammed hard. Shame on them (scammers). But… the company has never said they were going to do something they did not. (all in the PR leading up to bloodstreet).
Peace and love. And in the words of the The Big Lebowski, the words that inspired me to hold and watch perhaps the most incredible day of the most harsh treatment a penny stock ever received….
“F#ck it dude”
Ok.. I’m done ranting. Feels good to get it out there.
